Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis.
about
Clinical Application of Antimicrobial Bone Graft Substitute in Osteomyelitis Treatment: A Systematic Review of Different Bone Graft Substitutes Available in Clinical Treatment of OsteomyelitisNanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisBiofilms in periprosthetic orthopedic infectionsChitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitisA resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect modelNanoparticulate drug delivery platforms for advancing bone infection therapies.Poly(trimethylene carbonate) as a carrier for rifampicin and vancomycin to target therapy-recalcitrant staphylococcal biofilms.In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections.Combination therapy with vancomycin-loaded calcium sulfate and vancomycin-loaded PMMA in the treatment of chronic osteomyelitis.In vitro and in vivo drug release and antibacterial properties of the novel vancomycin-loaded bone-like hydroxyapatite/poly amino acid scaffold.Applying biodegradable particles to enhance cancer vaccine efficacy.Chitosan coatings to control release and target tissues for therapeutic delivery.In Vitro Activity of Gentamicin-Loaded Bioabsorbable Beads against Different Microorganisms.Bio-absorbable antibiotic impregnated beads for the treatment of prosthetic vascular graft infections.Antifouling and antimicrobial biomaterials: an overview.Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant.Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model.Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: an in vitro elution studyA novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitisDoes implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro?Nanoparticle-based local antimicrobial drug delivery.Size and composition of synthetic calcium sulfate beads influence dissolution and elution rates in vitro.Osteogenic and antibacterial properties of vancomycin-laden mesoporous bioglass/PLGA composite scaffolds for bone regeneration in infected bone defects.Effect of Low-Frequency Pulsed Ultrasound on Drug Delivery, Antibacterial Efficacy, and Bone Cement Degradation in Vancomycin-Loaded Calcium Phosphate Cement.In vivo quantification of gentamicin released from an implant coating.Antimicrobial Activity of 3D-Printed Poly(ε-Caprolactone) (PCL) Composite Scaffolds Presenting Vancomycin-Loaded Polylactic Acid-Glycolic Acid (PLGA) MicrospheresSynthesis, Properties, and In Vitro Hydrolytic Degradation of Poly(d,l-lactide-co-glycolide-co-ε-caprolactone)
P2860
Q26767155-85D5D432-E38E-4D67-AC24-AC5B2E6A7378Q28086953-34EAD250-7F2B-4F92-AB4D-34400FEB84BDQ28392406-FB485C49-8884-4CBC-9E1B-B1632D5D8399Q34686765-B051E80F-5972-4BE3-9C16-D8E69F580B57Q35225221-B76554E3-5BCE-4B72-962E-40F663564849Q35373671-1AFAD074-63E1-4E36-B0D0-7D6209FEED70Q35923715-654B8BE0-46F3-488A-9919-9EAAB2CF6C6DQ36059113-2B88FBE9-F492-4EF4-BFC8-0C66AC4EA713Q36231856-C17CE899-6403-4482-9F5A-9EC8EB3517ECQ37702416-834BEBF3-3E05-4C43-8FAA-4765E21EAE58Q38212549-8472FE34-DEF2-45B9-802B-FEBA0C626038Q38558105-73A1C507-1341-4F80-9F83-0B7924227296Q38623078-30984A80-E0EE-4357-A30C-2FF92CC67B27Q38741715-CBEA7185-A1C6-4C48-8585-9D0E2C091EC6Q39240773-368E595F-AB6D-4F98-BC3C-30A968E3A2D4Q41211868-11D93C43-067C-49C1-B982-D3CBD4AC3923Q41586328-74061C80-03DB-447F-BAB9-F06DC8E027AFQ41688660-980215BB-659A-4A34-ADA7-F79824916271Q41762519-957FF99C-F5C8-4264-A02C-1955F98A7522Q41865616-73033E8F-0070-474C-8437-B0E078D085E3Q41976517-9CE6594E-8E19-407F-933E-2493EFDAAA82Q46223691-CAC6EEB2-ED5D-48EF-B880-1621A52AA575Q47203486-A5CC4D82-79AE-4F01-9BAB-A470028DDF43Q47371871-C4EA4B0C-86F8-4596-BF66-CA89DD760E21Q50054915-94087C0F-6963-41C1-AE2C-533596881443Q51529189-6D218C27-AD22-4E0C-8194-3F679FE78308Q58795247-FC1D3701-9312-4DC2-93C2-B0C3B53E4C39Q59124959-FB943071-B74E-40D8-9E69-E25F489EFE31
P2860
Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biodegradable vs non-biodegrad ...... he treatment of osteomyelitis.
@en
type
label
Biodegradable vs non-biodegrad ...... he treatment of osteomyelitis.
@en
prefLabel
Biodegradable vs non-biodegrad ...... he treatment of osteomyelitis.
@en
P2093
P2860
P1476
Biodegradable vs non-biodegrad ...... he treatment of osteomyelitis.
@en
P2093
Daniëlle Neut
Henk J Busscher
Henny C van der Mei
Otto S Kluin
P2860
P304
P356
10.1517/17425247.2013.751371
P407
P577
2013-01-06T00:00:00Z